Brought to you by www.DealSearchOnline.com
July 16, 2012 Issue:
Recent Health Care M&A Deals
Amylin Gets Bid Up-
Bristol-Myers Squibb Finishes What It Started In February
Spotlight on: E-Health
Conference Calendar
Recent Health Care M&A Deals
HOSPITALS
Acquirer
Target
Price
Restora Healthcare Holdings
Trillium Specialty Hospitals
N/A
LABORATORIES, MRI AND DIALYSIS
Acquirer
Target
Price
Luminex Corporation
GenturaDx
$50.0 million
MANAGED CARE
Acquirer
Target
Price
WellPoint, Inc.
Amerigroup Corporation
$4.9 billion
OTHER
Acquirer
Target
Price
Omnicare, Inc.
Five Star’s Pharmacy Business
$30.7 million
BioRx
Coagulife Pharmacy
N/A
How can we serve you better? Complete our brief survey for a chance to win $250 from AMEX!
What is most important to your business? Is there something you would like to see in one of our publications? We are dedicated to being an integral part of keeping your business ahead of the competition. We would love to hear from you. Fill out our brief publications survey and you will be entered for a chance to win one of two $250 American Express gift cards! http://www.levinassociates.com/pubsurvey
Amylin Gets Bid Up-
Bristol-Myers Squibb Finishes What It Started In February
Hindsight always helps, but it looks like the board of Amylin (NASDAQ: AMLN) had it right when they rejected the unsolicited bid from Bristol-Myers Squibb (NYSE: BMY) last February for $22.00 per share. It was a decent premium of nearly 100% above AMLN’s price before it announced the results of its new diabetes drug treatment……Read more
Is Your Company a Power User of Merger and Acquisition Data?
Drive the price of data down to less than 3 cents per item. Call 1-800-248-1668 to learn about our frequency discounts. Go to http://www.dealsearchonline.com, an easy-to-use, award-winning database. This specialized database is an essential 24/7 source for details on health care mergers and acquisitions covering 13 sectors. With approximately 20,000 records of investments and contact names (including e-mail addresses), you’ll get the information you need to make an informed decision any time of the day or night. Call 1-800-248-1668 to learn about our frequency discounts.
Spotlight on: E-Health
Abbott Laboratories (NYSE: ABT) is entering into an agreement with Action Pharma A/S to develop and commercialize Action’s AP214, a compound to prevent acute kidney injury associated with major cardiac surgery. Under terms of the deal, ABT will pay Action, a company based in Denmark, $110.0 million upfront……..Read more
Conference Calendar…Click here to see more
